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We have read with interest the editorial of Mascalchi and 
colleagues, on our study “Exposure to low dose computed 
tomography for lung cancer screening and risk of cancer: secondary 
analysis of trial data and risk-benefit analysis” (1).
Their comments are certainly pertinent and clearly 
present the state-of-the-art concerning cancer risk 
associated with low-dose radiation exposure. This topic 
is however controversial and the scientific community 
recognize that much of low-dose radiation risk is still 
unknown, with a significant level of uncertainty in the 
definition of actual risk for subjects that undergo low-dose 
CT for lung cancer screening.
In particular, there are several aspects to be considered 
when evaluating the quantitative risk from low-dose 
radiation exposure. In fact, the risk-benefit analysis of low-
dose CT screening is very much influenced by the risk 
profile and age of the subject, by the design of the screening 
program and by the CT technology used (with particular 
regard to scanning parameters).
The reduction of radiation risk in CT screening begins 
from an optimal patient selection (subjects at higher risk) 
and the definition of an accurate study design, which are 
essential for minimizing unnecessary radiation exposure. 
Our study reported a median cumulative effective dose at 
the 10th year of screening of 9.3 mSv for men and 13.0 mSv 
for women. The overall additional risk of induced major 
cancers was low (0.05%; 2.4 major cancers theoretically 
induced over 5,203 screened subjects), with a greater risk 
for women aged 50–54 [lifetime attributable risk (LAR) 
of major cancers was about three-fold higher than for 
men aged 65 or more]. Most importantly, we estimated 
1 radiation induced major cancer every 108 lung cancers 
detected (1).
Risk estimates performed in our study can be considered 
substantially low, even if we use the BEIR VII Report (2) 
and the linear no-threshold (LNT) model, for which the 
inferred risk at lower doses probably overestimates the 
risk of cancer induction. In fact, the LAR of the BEIR 
VII has been estimated from the data obtained from 
the atomic bomb survivors and from the nuclear energy 
industry workers, exposed to doses much higher than those 
associated with LDCT screening. Cancer risk related to 
radiation exposure has therefore been extrapolated from 
high-dose to low-dose levels, using a LNT model.
Observational, experimental and radiobiological data 
may show, however, that LNT might underestimate or 
overestimate the risk from low-dose radiation. Moreover, 
a part of the scientific community claims that there is a 
threshold and warns against risk estimation when dealing 
with doses below a certain level (50–100 mSv), as the risk 
might be too small to be observed or even non-existent (3). 
The risk of radiation-induced cancer is still controversial, 
with the LNT model representing a cautionary approach 
that overestimates the risk related to low-dose radiation 
exposure (4).
What we should take into consideration when interpreting 
the results of our study is that we did not use iterative 
reconstruction algorithms and dose-reduction techniques: 
such advances in CT technology (currently implemented in 
all modern scanners) can dramatically reduce the radiation 
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dose delivered to patients. Several studies, for example, 
have reported a dose reduction of up to 80% with iterative 
reconstruction, while achieving the same image quality as with 
FBP, with sub-milliSievert effective dose (below 0.2 mSv) (5,6). 
Considering the LNT model, then, the risk of radiation induced 
cancer, would be reduced to the same extent, up to 80%.
Another topic of growing interest, in our opinion, is the 
use of advanced software for the calculation of organ doses 
and hence effective doses (7). In fact, the dose delivered to 
patients depends on scanning parameters and on the size 
of the patient: software that uses different phantoms to 
estimate organ doses might be more accurate than those 
that use the standard reference patient only.
In conclusion, we firmly believe that the benefit of lung 
cancer screening in terms of mortality reduction outweighs 
the risk of radiation-induced cancer, and recent advances 
in CT technology will further reduce the radiation risk 
associated with low-dose CT.
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